Anti-Microbial Peptidomimetic Development Service
It is of great interest to develop novel antimicrobial peptidomimetics and counteract microorganisms by physically disrupting the microbial lipid bilayer and inducing leakage of cellular contents.
|
Anti-Viral Peptidomimetic Development Service
Peptidomimetics have stronger stability and can resist the metabolic degradation pathways of the body to reach the site of action, and have become one of the effective strategies for anti-viral therapy.
|
Anti-Cancer Peptidomimetic Development Service
Various proteins or peptidases play key roles in cancer development, so there is great potential to develop peptidomimetics as lead compounds for cancer therapeutics.
|
Anti-Oxidant Peptidomimetic Development Service
Many peptides and their derivatives have been shown to have antiaging, antihypertensive, neurodegenerative and other antioxidant-mediated properties, so the development of related peptidomimetics has medicinal value.
|
|
Anti-Glycation Peptidomimetic Development Service
Advanced glycation end products (AGEs) can cause cell dysfunction, damage target organs, and cause various diseases such as diabetes. Therefore, the development of peptidomimetics to inhibit AGEs is of great value.
|
Anti-Malarial Peptidomimetic Development Service
Anti-malarial peptides show significant anti-malarial advantages, but there are few clinically available anti-malarial peptide drugs due to the low bioavailability and poor efficacy. The development of peptidomimetics can solve the above drawbacks.
|
Analgesic Peptidomimetic Development Service
Most of the drugs currently used to treat pain are ineffective, have certain toxicity, and cannot be used for a long time. Therefore, research and discovery of new drugs are urgently needed, and peptidomimetics have important analgesic potential.
|
Immunosuppressive Peptidomimetic Development Service
Many immunosuppressants have been used to treat autoimmune diseases, etc., but they tend to affect the entire immune system, leading to severe toxicity. The development of peptidomimetics can effectively solve this drawback.
|
